Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21081550 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Drug: A-002

Indicates status has not been verified in more than two years